Trial Profile
Follow-on phase III study of imetelstat in patients with acute myelogenous leukaemia
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Mar 2015
Price :
$35
*
At a glance
- Drugs Imetelstat (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Geron Corporation
- 12 Mar 2015 New trial record